News - Biogen Idec, Royalty Pharma


Current filters:

Biogen IdecRoyalty Pharma

Popular Filters

Elan puts up formal "for sale" notice


Ireland-based Elan Corp (NYSE:ELN), which has been the subject of a hostile takeover campaign by private…

Biogen IdecElanMergers & AcquisitionsPharmaceuticalRoyalty Pharma

Elan to unlock benefits for shareholders from Tysabri deal


The board of Ireland-based drugmaker Elan Corp (NYSE:ELN) has approved the decision to initiate a unique…

Biogen IdecBiotechnologyElanFinancialMergers & AcquisitionsPharmaceuticalRoyalty PharmaTysabri

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top